Category Filter
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Policies
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
Genetic Testing Policies - Blue Advantage
Blue Cross and Blue Shield of Alabama partners with Carelon Medical Benefits Management, an independent company, to administer genetic testing solutions for our customers.
Carelon is our business associate and has agreed to follow our privacy and security policies regarding the confidentiality and protection of personal health information.
For more information about the Genetic Testing program, click here.
Current Genetic Testing Policies
To continue to the Carelon Medical Benefits Management website to view genetic testing policies, click "Accept” below.
For Medicare Local or National Coverage Determinations (LCD/NCD) click here.
Blue Advantage will follow Palmetto GBA MolDX* when there is no Local Coverage Determination or National Coverage Determination related to a Molecular Diagnostic Test.
Precertification of Genetic Testing Services
Some genetic testing services require precertification. Click the link below to view a list of applicable CPT/HCPCS codes.